For your right to be curious.

Donate

Play Live Radio

Next Up:

0:00

0:00 0:00

Available On Air Stations

Build a transformational philanthropy program for this trusted NPR affiliate.
Seeking a 100% major gift fundraiser passionate about public media to develop relationships with people who support an informed and civil central Illinois.
Hire will have community visibility, many prospects, and professional resources.
Interviews in progress, open until filled. Apply now.

Are you availabile to be a local fill-in anchor on Morning Edition and/or All Things Considered?
Must be available with notice either weekdays from 5:30 to 9 a.m. and/or 3:30 to 6 p.m.
Apply by June 5, 5 p.m.

New study finds immunotherapy fights difficult-to-treat types of brain cancer

WBUR | By Here & Now Newsroom

Published June 5, 2025 at 10:58 AM CDT

Researchers are praising the results of two studies that used immunotherapy to fight one of the most difficult-to-treat types of brain cancer, glioblastoma. The studies used CAR-T therapy, which uses engineered T cells to fight the cancer.

Angus Chen, cancer reporter at STAT, joins us to discuss what the results mean for the fight against brain cancer.

This article was originally published on WBUR.org.

Here & Now Newsroom